Moraceae Lab Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 5.40 M
- Company Age 26 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.37 Cr
- Revenue Growth %
- Profit Growth 59.99%
- Ebitda 87.74%
- Net Worth -2.77%
- Total Assets -0.84%
About Moraceae Lab
Moraceae Lab Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 May 1998 and has a history of 26 years and eight months. Its registered office is in Uttar Pradesh, Uttar Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.40 M.
The company has closed loans amounting to ₹2.37 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ravindra Singh and Shatrupa Singh serve as directors at the Company.
Company Details
-
LocationUttar Pradesh, Uttar Pradesh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233UP1998PTC023472
-
Company No.
023472
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 May 1998
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Moraceae Lab?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Singh
|
Director | 28-Mar-2002 | Current |
|
Shatrupa Singh
|
Director | 03-Feb-2021 | Current |
Financial Performance of Moraceae Lab.
Moraceae Lab Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 59.99% increase in profit. The company's net worth dipped by a decrease of 2.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Moraceae Lab?
In 2016, Moraceae Lab had a promoter holding of 58.46% and a public holding of 41.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Moraceae Pharmaceuticals Private LimitedRavindra Singh and Shatrupa Singh are mutual person
Charges (Loans)
₹0
₹23.70 M
Charges Breakdown by Lending Institutions
- Union Bank Of India : 2.37 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2004 | Union Bank Of India | ₹1.41 Cr | Satisfied |
| 03 Dec 2002 | Union Bank Of India | ₹9.60 M | Satisfied |
How Many Employees Work at Moraceae Lab?
Unlock and access historical data on people associated with Moraceae Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Moraceae Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Moraceae Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
